AI Science Tracker
EN

An Adaptive Transfer-Learning-Based Deep Cox Neural Network for Hepatocellular Carcinoma Prognosis Prediction

School of Mathematics and Big Data, Foshan University, China · 27 Sep 2021 · medicine

Discovery

An Adaptive Transfer-Learning-Based Deep Cox Neural Network for Hepatocellular Carcinoma Prognosis Prediction

Source check: Source checked. Not independent scientific confirmation.

Finding: TCGA training and three independent GEO tests support robustness; the study identifies markers including TTC36 and reports cell experiments. Independent datasets and cell assays support the study-specific result, not treatment efficacy or prospective patient benefit.

Technology: An adaptive transfer-learning deep Cox network selects pretraining cancer types and predicts hepatocellular-carcinoma survival from expression data.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
An adaptive transfer-learning deep Cox network selects pretraining cancer types and predicts hepatocellular-carcinoma survival from expression data.
Test and result
TCGA training and three independent GEO tests support robustness; the study identifies markers including TTC36 and reports cell experiments.
Limitation / still unknown
Independent datasets and cell assays support the study-specific result, not treatment efficacy or prospective patient benefit.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.692774/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.